RCT of Automated Conversational Agent vs. Treatment as Usual for the Management of Perinatal Mood
NCT ID: NCT03646539
Last Updated: 2020-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
201 participants
INTERVENTIONAL
2018-10-01
2019-07-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Maternal Depression and Promoting Infant Social-Emotional Health & Development
NCT03464630
Preventing Depressive Relapse in Pregnant Women With Recurrent Depression
NCT03623620
Evaluating Screening Adherence Between Moment for Parents App and Attention Control
NCT07322042
Virtual Reality-enhanced Psychotherapy for Perinatal Depression
NCT07279311
Preventing Perinatal Depression with an App-Based CBT Program
NCT06672432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smartphone use + treatment as usual
Participants will receive treatment as usual and use the smartphone app for the management of mood.
Use of smartphone application (app)
Use of a CBT-based automated conversational agent available as a mobile device smartphone application for the management of mood.
Treatment as usual
Treatment as usual will include (but may not be limited to) the participant's 6-week postpartum follow-up visit with their obstetrics care team. Participants will be sent surveys to evaluate their depressive and anxiety symptoms.
Treatment as usual
Participants will receive treatment as usual.
Treatment as usual
Treatment as usual will include (but may not be limited to) the participant's 6-week postpartum follow-up visit with their obstetrics care team. Participants will be sent surveys to evaluate their depressive and anxiety symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of smartphone application (app)
Use of a CBT-based automated conversational agent available as a mobile device smartphone application for the management of mood.
Treatment as usual
Treatment as usual will include (but may not be limited to) the participant's 6-week postpartum follow-up visit with their obstetrics care team. Participants will be sent surveys to evaluate their depressive and anxiety symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medically stable and cleared for discharge
* Owns smartphone
* English-speaking (because all intervention materials are in English)
Exclusion Criteria
* Intrauterine fetal demise this admission
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy Judy
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy Judy, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University Department of Obstetrics and Gynecology
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Ment Health. 2017 Jun 6;4(2):e19. doi: 10.2196/mental.7785.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-46467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.